Latest Health News from Duke Medicine News and Communications
Duke launches autism app with global reach
Oct. 15, 2015
A team of researchers and software developers from Duke University and the Duke Medical Center has introduced a free iOS app to learn more about autism in young children living around the world.
Drug-resistant E. coli continues to climb in community health settings
Oct. 13, 2015
Drug-resistant E. coli infections are on the rise in community hospitals, where more than half of U.S. patients receive their health care, according to a new study from Duke Medicine.
DCIS Treatments Evolve Over 20 Years, But Cancer Death Rates Vary Little
Oct. 9, 2015
Treatment patterns for ductal carcinoma in situ (DCIS) have shifted since the 1990s, with more U.S. women opting for lumpectomy in combination with radiation rather than single-breast mastectomy, according to a study lead by Duke Cancer Institute researchers.
Cleaning Hospital Rooms With Chemicals, UV Rays Cuts Superbug Transmissions
Oct. 7, 2015
In a hospital, what you can’t see could hurt you.
Paul Modrich Shares Nobel Prize in Chemistry for Work in DNA Repair
Oct. 7, 2015
Paul Modrich, Ph.D., the James B. Duke professor of biochemistry in the Duke University School of Medicine, has been awarded one-third of this year’s Nobel Prize in Chemistry for his four decades of work on how mistakes in the DNA code are repaired.
Duke Establishes First Hand Transplant Program in North Carolina
Oct. 5, 2015
Duke Medicine has launched the first hand transplant program in North Carolina, becoming one of a small number of transplant centers in the country to offer the life-altering procedure.
Meningitis Model Shows Infection’s Sci-Fi-Worthy Creep Into the Brain
Sept. 29, 2015
Scientists at Duke Medicine are using transparent fish to watch in real time as Cryptococcal meningitis takes over the brain. The resulting images are worthy of a sci-fi movie teaser, but could be valuable in disrupting the real, crippling brain infection that kills more than 600,000 people worldwide each year.
DART Protein Shows Potential as Shock-and-Kill Strategy Against HIV
Sept. 28, 2015
A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system’s killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.
Newly Identified Biochemical Pathway Could Be Target For Insulin Control
Sept. 24, 2015
In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.
New Mouse Brain Connectome May Illuminate Origins of Mental Illnesses
Sept. 15, 2015
Scientists at Duke University have released a highly detailed model of connections in the mouse brain that could provide generations of neuroscientists new insights into brain circuits and origins of mental illness, such as depression and schizophrenia. The findings are published in the journal Cerebral Cortex.